Over the last month a Named Patient Program has been developed in Australia and people below 40% FEV1 now have access to Kalydeco prior to TGA approval & PBS listing. The next step is TGA approval (like the FDA and EMA), hopefully Vertex will apply later this year. The TGA process is normally 9 months. After that it needs to be listed on the PBS so we can access it at a cheaper price! The PBS listing process is at least 4 months. So hopefully we are looking at the second half of next year...The updates from Cystic Fibrosis Australia have been uploaded here:http://www.cysticfibrosis.org.au/nsw/kalydecoinaustralia/There is also lots of information about Kalydeco & how we are trying to speed up the approval process for Kalydeco at the 'Kalydeco for Australians' facebook group. Anyone is welcome to join, particularly those from Australia!www.facebook.com/groups/343431685698805/